Business
The AstraZeneca jab and the price of fragmented decision-making – Al Jazeera English
Experts warn authorities’ divergent policies may damage trust and increase hesitancy in countries facing shortages.
Elena Hugony was sure about one thing as she entered a COVID-19 vaccination centre in the Italian city of Palermo last week: she was not going to allow to be injected with the AstraZeneca vaccine.
Sure enough, when a healthcare worker approached her with a shot of the jab developed by the Anglo-Swedish pharmaceutical giant and the University of Oxford, the 75-year-old stood firm to her conviction. With Hugony refusing to leave, a doctor finally relented after four hours and gave her a shot of the…
Continue Reading
